Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload - Fujimoto, Naoki; Sugimoto, Tadafumi; Kumagai, Naoto; Dohi, Kaoru; Tanimura, Muneyoshi; Sugiura, Emiyo; Nakamori, Shiro; Takeuchi, Tetsushiro; Watanabe, Kiyotaka; Ito, Masaaki; Sato, Yuichi; Ogura, Toru; et al. (International Heart Journal, 2016)
Keywords: Aged; Antidiuretic Hormone Receptor Antagonists - administration & dosage; Benzazepines - administration & dosage; Biomarkers - blood; Biomarkers - urine; Creatinine - urine; Diuresis; Diuresis - drug effects; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure - drug therapy; Heart Failure - metabolism; Heart Failure - physiopathology; Humans; Hyponatremia; Loop diuretics; Male; Natriuretic Peptide, Brain - blood; Prognosis; Retrospective Studies; Sodium - urine; Vasopressin V2-receptor antagonist; Ventricular Pressure